Condition
Small Cell Carcinoma of Lung clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Small Cell Carcinoma of Lung clinical trials that are recruiting, at sites in 3 countries (most in United States (1), South Korea (1), Poland (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Small Cell Carcinoma of Lung clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cardiorespiratory exercise testing before and during lung cancer treatment | — | Bialystok, Podlaskie Voivodeship | Recruiting | Apr 14, 2026 |
| AVA6103 for advanced or metastatic FAP-positive solid tumors | Phase 1 | Scottsdale, Arizona and 6 other locations | Recruiting | Mar 6, 2026 |
| Tarlatamab with carboplatin/etoposide and atezolizumab for EGFR‑mutant lung adenocarcinoma that changed into small cell lung cancer | Phase 2 | Seoul, Gangnam-gu | Recruiting | Feb 17, 2025 |
All recruiting trials (3)
-
Cardiorespiratory exercise testing before and during lung cancer treatment
This project tests whether a supervised exercise test (CPET) can measure heart and lung fitness in adults with lung cancer who are able to exercise (WHO/ECOG 0-2) before and during their treatment.
-
AVA6103 for advanced or metastatic FAP-positive solid tumors
This study will test whether the experimental IV drug AVA6103 is safe and can help adults with advanced or metastatic FAP-positive cancers such as pancreatic, gastric/GEJ, cervical, or vulvar adenocarcinomas.
-
Tarlatamab with carboplatin/etoposide and atezolizumab for EGFR‑mutant lung adenocarcinoma that changed into small cell lung cancer
This trial tests whether adding tarlatamab to standard platinum‑etoposide chemotherapy and atezolizumab helps patients whose EGFR‑mutant lung adenocarcinoma has transformed into small cell lung cancer.
Related topics
Quick answers
How many Small Cell Carcinoma of Lung clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (1 trial), South Korea (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.